These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16293350)

  • 1. Optimization of a pharmacophore model for 5-HT4 agonists using CoMFA and receptor based alignment.
    Iskander MN; Leung LM; Buley T; Ayad F; Di Iulio J; Tan YY; Coupar IM
    Eur J Med Chem; 2006 Jan; 41(1):16-26. PubMed ID: 16293350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
    Yuan H; Kozikowski AP; Petukhov PA
    J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
    Vermeulen ES; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2003 Dec; 46(25):5365-74. PubMed ID: 14640545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.
    Vermeulen ES; van Smeden M; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2004 Oct; 47(22):5451-66. PubMed ID: 15481983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological properties of benzamide derivatives as selective serotonin 4 receptor agonists.
    Sonda S; Katayama K; Kawahara T; Sato N; Asano K
    Bioorg Med Chem; 2004 May; 12(10):2737-47. PubMed ID: 15110855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
    Holder S; Lilly M; Brown ML
    Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
    Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
    J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands.
    Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN
    Eur J Med Chem; 2009 Jul; 44(7):2952-9. PubMed ID: 19223092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.
    Moro S; Braiuca P; Deflorian F; Ferrari C; Pastorin G; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
    J Med Chem; 2005 Jan; 48(1):152-62. PubMed ID: 15634009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved 3D-QSAR CoMFA of the dopamine transporter blockers with multiple conformations using the genetic algorithm.
    Yuan H; Petukhov PA
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6267-72. PubMed ID: 17027270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
    Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
    J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.
    McKinnell RM; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum A; Humphrey PP; Long DD; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    J Med Chem; 2009 Sep; 52(17):5330-43. PubMed ID: 19663444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
    Bissantz C; Schalon C; Guba W; Stahl M
    Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
    Becker DP; Flynn DL; Shone RL; Gullikson G
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of 5-hydroxytryptamine4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behavior.
    De Maeyer JH; Prins NH; Schuurkes JA; Lefebvre RA
    J Pharmacol Exp Ther; 2006 Jun; 317(3):955-64. PubMed ID: 16501067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.